Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• Globus Medical Acquires Higgs Boson Health to Expand Digital Care and AI Platforms: Globus Medical acquired Duke-incubated digital health developer Higgs Boson Health to integrate AI-driven patient engagement, remote monitoring, and perioperative management into its musculoskeletal surgical ecosystem.
• AMSSM and OpenEvidence Partner to Deliver AI Clinical Decision Support in Sports Medicine: The American Medical Society for Sports Medicine (AMSSM) entered a collaboration with OpenEvidence to co-develop specialized AI point-of-care clinical resources for sports medicine physicians.
• Tenon Medical Prices $3M Private Placement to Accelerate Catamaran® SI Joint Fusion Commercialization: Tenon Medical secured $3.0 million in private equity financing to fund commercial distribution and clinical education for its Catamaran® SI Joint Fusion system.

DAILY ANNOUNCEMENTS BY CATEGORY

Corporate, M&A & Digital Health

Globus Medical — Acquires Higgs Boson Health to Drive AI-Powered Episode-of-Care Solutions

• Summary: Globus Medical, Inc. (NYSE: GMED) announced the acquisition of Higgs Boson Health, a Durham, NC-based digital health company incubated out of Duke University. The acquisition expands Globus Medical's digital health suite, combining Higgs Boson's AI-enabled patient engagement and care management software with Globus's ExcelsiusGPS® robotic navigation ecosystem to optimize clinical workflows from preoperative planning through post-operative recovery.
• Key Details:
  • Device/System Name: Higgs Boson Digital Care Platform & ExcelsiusGPS® Ecosystem
  • Status: Strategic M&A Completed
  • Clinical Significance: Connects intraoperative robotic surgical navigation with remote patient tracking and education, improving patient compliance and streamlining post-operative outcome reporting.
• Original Source: Globus Medical Acquisition Announcement — GlobeNewswire

Sports Medicine & Clinical AI

AMSSM & OpenEvidence — Strategic Partnership to Co-Develop AI Sports Medicine Clinical Decision Tools

• Summary: The American Medical Society for Sports Medicine (AMSSM) and OpenEvidence announced an exclusive partnership to develop specialized AI-driven clinical resources for sports medicine clinicians and athletes. The collaboration incorporates AMSSM's clinical guidelines, position statements, and expert-authored sports medicine content into OpenEvidence's clinical decision support search platform.
• Key Details:
  • Device/System Name: AMSSM / OpenEvidence Sports Medicine Clinical AI Platform
  • Status: Strategic Educational & Clinical AI Partnership
  • Clinical Significance: Delivers rapid, evidence-grounded point-of-care guidance for clinicians evaluating acute musculoskeletal trauma, concussions, and return-to-play decisions.
• Original Source: AMSSM & OpenEvidence Partnership Announcement — OrthoSpineNews

Spine & Sacro-Pelvic Reconstruction

Tenon Medical — Announces Pricing of $3M Private Placement Offering for Catamaran® Expansion

• Summary: Tenon Medical, Inc. (NASDAQ: TNON) announced a securities purchase agreement for a $3.0 million private placement offering of common stock and accompanying warrants at an effective price of $5.02 per share. Net proceeds will fund nationwide commercial distribution, clinical trial evidence generation, and surgeon training for the Catamaran® Sacroiliac (SI) Joint Fusion System.
• Key Details:
  • Device/System Name: Catamaran® SI Joint Fusion System
  • Status: Private Placement Financing ($3.0M) / Commercial Expansion
  • Clinical Significance: Supports expanded surgeon access and training for single-transfixion posterior-inferior sacroiliac joint stabilization in outpatient and ASC settings.
• Original Source: Tenon Medical Private Placement Announcement — OrthoSpineNews

Spinal Elements — Commercial Launch of Overwatch® PCF Posterior Cervical Fixation System

• Summary: Spinal Elements announced the commercial launch of Overwatch® PCF, a posterior cervical fixation system engineered for complex cervical and occipito-cervico-thoracic reconstruction. The system features polyaxial screws offering 120 degrees of angulation, freely functioning low-profile tulips, and self-selecting set screws designed to simplify rod seating in crowded posterior cervical anatomy.
• Key Details:
  • Device/System Name: Overwatch® PCF Posterior Cervical Fixation System
  • Status: Commercial Launch / FDA 510(k) Cleared
  • Clinical Significance: Streamlines instrumentation and screw-rod assembly in multi-level posterior cervical fusions, reducing soft-tissue retraction strain and operative time.
• Original Source: Spinal Elements Overwatch PCF Launch — SPINEMarketGroup

NEW FDA 510(k) & PMA CLEARANCE LISTING (PAST 24–48 HOURS)